|
EID1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.58049999999488E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.661270E-03 |
| Normal-vs-Stage2 |
5.338800E-01 |
| Normal-vs-Stage3 |
1.75748999999836E-05 |
| Normal-vs-Stage4 |
9.84610000198671E-08 |
| Stage1-vs-Stage2 |
1.695970E-01 |
| Stage1-vs-Stage3 |
1.578080E-02 |
| Stage1-vs-Stage4 |
1.479240E-03 |
| Stage2-vs-Stage3 |
9.101000E-03 |
| Stage2-vs-Stage4 |
8.242200E-04 |
| Stage3-vs-Stage4 |
2.014800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.78150000005062E-06 |
| Normal-vs-AfricanAmerican |
1.897050E-01 |
| Normal-vs-Asian |
1.673390E-01 |
| Caucasian-vs-AfricanAmerican |
2.585400E-01 |
| Caucasian-vs-Asian |
5.006000E-02 |
| AfricanAmerican-vs-Asian |
7.919800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.998840E-04 |
| Normal-vs-Female |
2.390800E-04 |
| Male-vs-Female |
5.127200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.798290E-03 |
| Normal-vs-Age(41-60Yrs) |
3.960500E-04 |
| Normal-vs-Age(61-80Yrs) |
2.403000E-04 |
| Normal-vs-Age(81-100Yrs) |
3.779800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.187000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.725600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.847200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.966200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.099800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.084800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.372220E-02 |
| Classical-VS-Follicular |
2.325000E-01 |
| Classical-VS-Other |
7.766600E-01 |
| Classical-VS-Normal |
2.016700E-03 |
| Tall-VS-Follicular |
1.784060E-03 |
| Tall-VS-Other |
2.732600E-01 |
| Tall-VS-Normal |
2.10420000001932E-06 |
| Follicular-VS-Other |
5.466400E-01 |
| Follicular-VS-Normal |
1.086360E-01 |
| Other-VS-Normal |
8.232300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.500100E-03 |
| Normal-vs-N1 |
9.64669999992118E-07 |
| N0-vs-N1 |
4.804900E-03 |
|
|
